Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen S Atkins

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Microbial Pathogenesis|June 4, 2009
Enhanced vaccine antigen delivery by Salmonella using antibiotic-free operator-repressor titration-based plasmid stabilisation compared to chromosomal integrationMatthew W Leckenby, Abigail M Spear, Brendan N Neeson, et al.
Vaccine|January 26, 2006
Recombinant Salmonella vaccines for biodefenceHelen S Atkins, Margaret Morton, Kate F Griffin, et al.
Microbial Pathogenesis|January 26, 2010
A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infectionPetra C F Oyston, Gabriela Mellado-Sanchez, Marcela F Pasetti, et al.
Acta Crystallographica. Section D, Biological Crystallography|November 17, 2007
Structures of OppA and PstS from Yersinia pestis indicate variability of interactions with transmembrane domainsMikio Tanabe, Osman Mirza, Thomas Bertrand, et al.
International Journal of Antimicrobial Agents|August 25, 2009
Efficacy of the quinolones trovafloxacin and grepafloxacin for therapy of experimental tularaemia and plagueDermot J Kenny, Armine M Sefton, Jackie Steward, et al.
Microbial Genomics|October 4, 2019
Genome-wide assessment of antimicrobial tolerance in <i>Yersinia pseudotuberculosis</i> under ciprofloxacin stressSamuel Willcocks, Kristin K Huse, Richard Stabler, et al.
Vaccine|September 23, 2008
Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategyLeslie W J Baillie, Ana L Rodriguez, Stephen Moore, et al.
International Journal of Antimicrobial Agents|May 14, 2010
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosisDermot J Kenny, Armine M Sefton, Timothy J G Brooks, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomalleiKay B Barnes, Karleigh A Hamblin, Mark I Richards, et al.
Frontiers in Microbiology|May 24, 2019
The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With <i>Francisella tularensis</i> Strain SchuS4Kay B Barnes, Karleigh A Hamblin, Mark I Richards, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Microbial Pathogenesis|June 4, 2009
Enhanced vaccine antigen delivery by Salmonella using antibiotic-free operator-repressor titration-based plasmid stabilisation compared to chromosomal integrationMatthew W Leckenby, Abigail M Spear, Brendan N Neeson, et al.
Vaccine|January 26, 2006
Recombinant Salmonella vaccines for biodefenceHelen S Atkins, Margaret Morton, Kate F Griffin, et al.
Microbial Pathogenesis|January 26, 2010
A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infectionPetra C F Oyston, Gabriela Mellado-Sanchez, Marcela F Pasetti, et al.
Acta Crystallographica. Section D, Biological Crystallography|November 17, 2007
Structures of OppA and PstS from Yersinia pestis indicate variability of interactions with transmembrane domainsMikio Tanabe, Osman Mirza, Thomas Bertrand, et al.
International Journal of Antimicrobial Agents|August 25, 2009
Efficacy of the quinolones trovafloxacin and grepafloxacin for therapy of experimental tularaemia and plagueDermot J Kenny, Armine M Sefton, Jackie Steward, et al.
Microbial Genomics|October 4, 2019
Genome-wide assessment of antimicrobial tolerance in <i>Yersinia pseudotuberculosis</i> under ciprofloxacin stressSamuel Willcocks, Kristin K Huse, Richard Stabler, et al.
Vaccine|September 23, 2008
Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategyLeslie W J Baillie, Ana L Rodriguez, Stephen Moore, et al.
International Journal of Antimicrobial Agents|May 14, 2010
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosisDermot J Kenny, Armine M Sefton, Timothy J G Brooks, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomalleiKay B Barnes, Karleigh A Hamblin, Mark I Richards, et al.
Frontiers in Microbiology|May 24, 2019
The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With <i>Francisella tularensis</i> Strain SchuS4Kay B Barnes, Karleigh A Hamblin, Mark I Richards, et al.
Pageof 7